Track topics on Twitter Track topics that are important to you
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institutefunded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
The global Paclitaxel market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export import
Key manufacturers manufacturing sites, capacity and production, product specifications etc.
Average market price by SUK
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Hainan Yew Pharm
Major applications as follows:
Regional market size, production data and export import:
Middle East AfricaNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...